Clinical and economic analysis of the 1st and 2nd target lines in oncological incidence and associated mortality. Renal cell
carcinoma (RCC) takes the 2nd place after prostate
Impact of organotin compounds on the growth of epidermoid Lewis carcinomaImpact of organotin compounds on the growth of epidermoid Lewis
carcinoma Renal cell carcinoma drug and cell therapy: today and tomorrowRenal cell
carcinoma drug and cell therapy: today and tomorrow
Asymptomatic Hepatocellular Carcinoma (Clinical Case)Asymptomatic Hepatocellular
Carcinoma (Clinical Case)